Recombinant Human IFN-α2 (carrier-free) | BioLegend 592702 product information

product summary

company name :

BioLegend

other brands :

Babco, Signet, Sternberger Monoclonals, Senetek, Covance

product type :

protein

product name :

Recombinant Human IFN-α2 (carrier-free)

catalog :

592702

quantity :

10 μg

price :

147 USD

more info or order :

BioLegend product webpage

citations: 12

Reference
Zhou Y, Li X, Shen R, Wang X, Zhang F, Liu S, et al. Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways. Front Immunol. 2022;13:884399 pubmed publisher
Xiang H, Toyoshima Y, Shen W, Wang X, Okada N, Kii S, et al. IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells. Cancer Sci. 2022;113:2513-2525 pubmed publisher
You J, Wu W, Lü M, Xie Y, Miao R, Gu M, et al. Hepatic exosomes with declined MiR-27b-3p trigger RIG-I/TBK1 signal pathway in macrophages. Liver Int. 2022;42:1676-1691 pubmed publisher
He Y, Gallman A, Xie C, Shen Q, Ma J, Wolfreys F, et al. P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance. J Exp Med. 2022;219: pubmed publisher
Zhang Z, Yang A, Chaurasiya S, Park A, Lu J, Kim S, et al. CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. Cancer Gene Ther. 2022;29:722-733 pubmed publisher
Chang A, Zhou Y, Iyengar S, Pobiarzyn P, Tishchenko P, Shah K, et al. Modulation of SF3B1 in the pre-mRNA spliceosome induces a RIG-I-dependent type I IFN response. J Biol Chem. 2021;297:101277 pubmed publisher
Stebbing J, Sánchez Nievas G, Falcone M, Youhanna S, Richardson P, Ottaviani S, et al. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021;7: pubmed publisher
Sun N, Li C, Li X, Deng Y, Jiang T, Zhang N, et al. Type-IInterferon-Inducible SERTAD3 Inhibits Influenza A Virus Replication by Blocking the Assembly of Viral RNA Polymerase Complex. Cell Rep. 2020;33:108342 pubmed publisher
Maroun J, Penza V, Weiskittel T, Schulze A, Russell S. Collateral Lethal Effects of Complementary Oncolytic Viruses. Mol Ther Oncolytics. 2020;18:236-246 pubmed publisher
Brazee P, Morales Nebreda L, Magnani N, Garcia J, Misharin A, Ridge K, et al. Linear ubiquitin assembly complex regulates lung epithelial-driven responses during influenza infection. J Clin Invest. 2020;130:1301-1314 pubmed publisher
Guo J, Muse E, Christians A, Swanson S, Davila E. An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell-Based Cancer Vaccine. Cancer Immunol Res. 2019;7:1523-1534 pubmed publisher
Burel J, Apte S, Groves P, Klein K, McCarthy J, Doolan D. Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production. PLoS Pathog. 2016;12:e1005839 pubmed publisher

product information

Antigen :

IFN-alpha2

Apps. Abbrev. :

Cat # :

592702

Item :

Recombinant Human IFN-α2 (carrier-free)

Other Names :

IFN-alpha 2B, IFN-alphaA, IFNA2, IFNA2B

Size :

10 μg

Price (USD) :

147 USD

Reactivity :

Human

Host :

ADD EXPRESSION SYSTEM HERE

Conjugate/Tag/Label :

RECOM

Application Notes :

This recombinant protein is encoded by the human IFN-a2B isoform.;BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.;

more info or order :

BioLegend product webpage